Diphtheria – Diagnostics – Overview of Information and Clinical Research

Diagnosing diphtheria requires quick action because this serious bacterial infection can progress rapidly and cause life-threatening complications. Healthcare providers rely on a combination of clinical observations and laboratory tests to confirm the presence of the disease, but treatment often begins before all test results are available due to the urgency of the situation.

Introduction: Who Should Undergo Diagnostics

Determining who needs to be tested for diphtheria is crucial for protecting both the individual and the wider community. Anyone who develops specific symptoms after traveling to regions where diphtheria is still present should seek medical attention immediately. This is especially important if you’ve visited parts of Africa, South America, India, Southeast Asia, or Eastern Europe, where the disease remains more common than in developed countries.^[1]

Healthcare providers will want to examine you urgently if you’ve been in close contact with someone diagnosed with diphtheria. Close contact means living in the same household, spending frequent time together, or being directly exposed to secretions from an infected person’s mouth, nose, or skin wounds. These situations put you at significant risk even if you don’t feel sick yet, because some people carry and spread the bacteria without showing any symptoms themselves.^[3]

Children under five years old and adults over 60 face particularly high risks from diphtheria and should be evaluated promptly if they develop suspicious symptoms. People who haven’t completed their vaccination series or haven’t received a booster shot in more than ten years are also more vulnerable. If you have a weakened immune system due to illness or medication, you should be especially vigilant about seeking diagnostic testing when symptoms appear.^[2]

The timing of diagnostic testing matters greatly. Symptoms typically appear between two and five days after exposure to the bacteria, though this window can range from one to ten days. If you develop a severe sore throat along with a thick, grey coating in your throat, swollen neck glands, difficulty breathing or swallowing, fever, or unusual fatigue after potential exposure, you should contact a healthcare provider immediately rather than waiting to see if symptoms improve on their own.^[1]

⚠️ Important

Don’t wait for all symptoms to develop before seeking help. Call your healthcare provider before visiting in person if you suspect diphtheria, as they may need to arrange special precautions to prevent the infection from spreading to others in the waiting room. Early diagnosis can be lifesaving because diphtheria progresses quickly and can cause heart damage, nerve problems, and breathing difficulties that become harder to treat as time passes.

Classic Diagnostic Methods

Healthcare providers typically begin the diagnostic process by carefully examining your throat and neck. The hallmark sign they look for is a thick, grey or white membrane covering the back of your throat, tonsils, or nasal passages. This distinctive coating, which is made up of dead cells and bacteria, sets diphtheria apart from more common throat infections like strep throat. The membrane can be quite fuzzy in appearance and may have a grey or even black color.^[1]

During the physical examination, your doctor will also check for swollen lymph nodes in your neck, which often become enlarged in diphtheria cases. They’ll listen to your breathing for any unusual sounds, such as a harsh, high-pitched noise called stridor, which occurs when the airways become narrowed. The provider will assess how easily you can breathe and swallow, as the membrane can sometimes grow large enough to block the airway. They’ll also check your temperature, heart rate, and other vital signs to gauge how severely the infection is affecting your body.^[2]

The definitive diagnosis comes from laboratory testing of samples taken from your throat or nose. A healthcare provider will use a swab to collect material from the affected area, particularly from the membrane if one is visible. If you have skin sores that might be caused by diphtheria, samples will be taken from those wounds as well. The swabbing procedure itself is quick and relatively simple, though it may cause brief discomfort when the swab touches the back of your throat.^[3]

Once collected, these samples are sent to a laboratory where specialists attempt to grow, or culture, any bacteria present. Growing the bacteria takes time, which is why doctors don’t wait for results before starting treatment if they strongly suspect diphtheria. The laboratory technicians look specifically for Corynebacterium diphtheriae, the bacterium responsible for diphtheria. However, simply finding this bacterium isn’t enough to confirm a diphtheria diagnosis.^[2]

The critical step in laboratory diagnosis involves determining whether the bacteria found in your sample actually produce the dangerous toxin that causes the serious effects of diphtheria. Not all strains of Corynebacterium diphtheriae make this toxin. Laboratory staff must perform special tests to check whether the bacteria express the tox gene, which enables them to manufacture the harmful substance. This toxin production testing is the only way to definitively confirm that a patient has true diphtheria rather than a milder infection caused by non-toxin-producing strains.^[3]

In cases of suspected respiratory diphtheria, healthcare providers often start treatment immediately based on clinical appearance alone, without waiting for laboratory confirmation. This approach is necessary because diphtheria can worsen rapidly and cause permanent damage or death. The distinctive grey membrane combined with your symptoms and exposure history provides enough evidence for your doctor to begin presumptive therapy. Laboratory testing then serves to confirm the diagnosis and helps public health officials track cases and identify contacts who may need treatment.^[11]

For skin diphtheria, which affects the skin rather than the respiratory tract, diagnosis follows a similar pattern. Doctors will examine the affected skin areas for characteristic signs: painful open sores or ulcers, often covered by a grey membrane, along with redness, swelling, and sometimes a rash with peeling skin. Samples from these skin lesions are cultured in the same way as throat samples to identify the bacteria and test for toxin production.^[2]

Diagnostics for Clinical Trial Qualification

Clinical trials studying treatments for diphtheria would require stringent diagnostic criteria to ensure that participants truly have the disease. Based on standard medical practice, enrollment in such studies would likely begin with confirmed laboratory evidence showing the presence of toxin-producing Corynebacterium diphtheriae. Researchers would need both positive bacterial cultures from throat, nose, or skin samples and confirmation that the isolated bacteria express the tox gene and produce diphtheria toxin.^[3]

Trial protocols would probably establish specific clinical criteria that participants must meet. These might include visible presence of the characteristic grey or white pharyngeal membrane, documented fever above a certain threshold, measurable swelling of neck lymph nodes, and objective evidence of breathing or swallowing difficulties. Researchers would want to document the severity of disease at enrollment, which might involve scoring systems based on membrane size, degree of airway obstruction, and vital sign abnormalities.^[1]

For studies evaluating diagnostic tests themselves, researchers would need samples collected at specific time points following symptom onset. They would likely require paired samples: one taken at initial presentation and another after a defined interval, allowing comparison of test performance at different stages of infection. Documentation of exposure history would be essential, including details about travel to endemic regions or contact with confirmed cases within the typical incubation period of one to ten days.^[3]

Clinical trial screening would probably also assess for complications that diphtheria can cause. This could involve electrocardiograms to detect heart muscle damage or inflammation (myocarditis), neurological examinations to identify nerve problems, kidney function tests to check for organ damage, and blood tests to measure toxin levels in circulation. The presence or absence of these complications might determine eligibility for certain trials or placement in different study groups.^[2]

⚠️ Important

Participation in clinical trials requires informed consent and careful consideration of risks and benefits. Because diphtheria can be fatal even with treatment, any research protocol would need to ensure that participants receive established standard-of-care treatments alongside any experimental interventions being studied. Trials would exclude patients with certain severe complications or those unable to provide informed consent.

Vaccination status would be a crucial screening factor for clinical trials. Researchers would need to document whether participants had received complete primary vaccination series and booster doses, since immunity levels affect both disease severity and response to treatment. Blood tests measuring antitoxin antibody levels might be used to objectively assess immune protection, as these antibodies indicate how well someone’s body could fight off the diphtheria toxin.^[3]

Studies might also establish contact tracing requirements as part of their enrollment process. Identifying and testing close contacts of trial participants helps researchers understand transmission patterns and disease spread. This epidemiological data collection would involve obtaining throat and nasal cultures from household members and other close contacts, monitoring these individuals for symptom development during the incubation period, and documenting their vaccination histories.^[11]

Prognosis and Survival Rate

Prognosis

The outlook for someone diagnosed with diphtheria depends heavily on how quickly treatment begins and whether complications develop. When healthcare providers start treatment early with appropriate antibiotics and antitoxin, many patients recover without permanent damage. However, the disease can progress rapidly and affect multiple body systems. The diphtheria toxin can spread through the bloodstream and damage the heart, causing inflammation of the heart muscle or heart failure. It can also harm nerves throughout the body, leading to paralysis that may affect breathing or other muscle functions. Kidney failure represents another serious complication that worsens prognosis.^[2]

Several factors influence how well someone will recover from diphtheria. Children under five years old and adults over 60 tend to have more severe disease and worse outcomes. People who are unvaccinated or incompletely vaccinated face greater risks than those who received full vaccination series, even if their immunity has waned over time. Those with weakened immune systems due to other illnesses or medications are more likely to experience complications. The severity of disease at diagnosis also matters significantly—patients with extensive membrane formation blocking the airways or those who have already developed heart or nerve problems when they first seek care have poorer prognoses.^[2]

Survival rate

Diphtheria remains a deadly disease even with modern medical care. Without proper treatment, approximately 30 percent of people who develop diphtheria will die from the infection, with young children facing especially high mortality risks. Even when patients receive treatment including antibiotics and antitoxin, about one in ten people—or roughly 10 percent—still die from the disease and its complications. This 5 to 10 percent case fatality rate reflects how serious diphtheria remains despite available treatments.^[4]^[6]

The mortality rate varies depending on which form of diphtheria someone develops. Respiratory diphtheria, which affects the throat and airways, carries higher death rates than skin diphtheria. When diphtheria causes complete airway blockage, leading to suffocation, the outcome can be fatal within hours without emergency intervention such as insertion of a breathing tube. Deaths from diphtheria most commonly result from airway obstruction, severe heart damage, or complications of nervous system involvement. Vaccinated individuals who develop diphtheria tend to have milder disease and lower death rates compared to unvaccinated people.^[6]

#1 Clinical Trials Search in Europe